top of page
Lallemand makes strategic investment in Turkish enzyme company Livzym
Through its Swiss affiliate, Danstar Ferment, Lallemand has completed an equity investment in Livzym Biotechnologies.
Lallemand
The Cell Base is your one-stop shop for all cell-based news – helping you keep your finger on the pulse with the latest business updates and technological insights.
bottom of page